Bibliography
- Ichijo H, Nishida E, Irie K, Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275(5296):90-4
- Matsukawa J, Matsuzawa A, Takeda K, Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J Biochem 2004;136(3):261-5
- Takeda K, Matsuzawa A, Nishitoh H, Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 2003;28(1):23-9
- Takeda K, Shimozono R, Noguchi T, Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J Biol Chem 2007;282(10):7522-31
- Volynets GP, Chekanov MO, Synyugin AR, Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1). J Med Chem 2011;54(8):2680-6
- Volynets GP, Bdzhola VG, Kukharenko OP, Yarmoluk SM. Identification of ASK1 small-molecule inhibitors. Ukr Biochim J 2010;82(5):41-50
- Wang BH, Xu GY, Ho PY, Apoptosis Signal-Regulating Kinase 1 Inhibition Attenuates Cardiac Myocyte Hypertrophy and Fibroblast Collagen Synthesis Stimulated by Angiotensin II- and TGFbeta: Therapeutic Potential of ASK1 Inhibitors in Myocardial Remodelling American Heart Association 2011 [abstract 12344]
- Merck Serono SA. Triazolopyridine Compounds And Their Use As ASK Inhibitors. WO2009027283; 2009
- Takeda Pharmaceutical Co. Ltd. Fused Heterocyclic Compound. WO2008016131; 2008
- Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2009123986; 2009
- Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2010008843; 2010
- Takeda Pharmaceutical Co. Ltd. Pyrazolo [1, 5-A] Pyrimidine Derivatives As Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2011041293; 2011
- Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2011097079; 2011
- Gilead Sciences, Inc. Apoptosis Signal-Regulating Kinase Inhibitors. WO2012003387; 2012
- Gilead Sciences, Inc. Methods for identifying ASK1 inhibitors useful for preventing and/or treating cardiovascular diseases. US20070276050; 2007
- Gilead Sciences, Inc. Apoptosis Signal-Regulating Kinase Inhibitors. WO2011008709; 2011
- Sturchler E, Feurstein D, McDonald P, Duckett D. ASK1 and Its Role in Neurodegenerative Diseases, 219-232; in Neurodegenerative Diseases – Processes, Prevention, Protection and Monitoring Ed. Chang RCC InTech, December, 2011
- Karaman MW, Herrgard S, Treiber DK, A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008;26(1):127-32
- Bamborough P, Drewry D, Harper G, Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem 2008;51(24):7898-914